CT-based delta-radiomics signature of visceral adipose tissue for prediction of disease progression in ileal stricturing Crohn's disease
- PMID: 40214913
- DOI: 10.1007/s11604-025-01779-5
CT-based delta-radiomics signature of visceral adipose tissue for prediction of disease progression in ileal stricturing Crohn's disease
Abstract
Objectives: To establish and validate a model based on CT imaging during follow-ups for predicting the disease progression in ileal stricturing Crohn's disease (CD).
Methods: Between January 2014 and February 2024, a retrospective review was conducted on 71 patients (training, n = 49; test, n = 22) who were initially diagnosed with ileal stricturing CD. Disease progression referred to the development of penetrating diseases, the requirement for CD-related hospitalization or surgery during follow-up. Radiomics features were extracted from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) on baseline and follow-up CT scans, respectively. Integrating clinical characteristics and body composition features, a novel CT-based delta-radiomics nomogram was established according to multivariate Cox stepwise regression analysis. Receiver operating characteristic (ROC) analysis was performed to assess diagnostic performance.
Results: The delta-VAT radiomics model (RM) exhibited satisfactory performance in training cohort (the area under the ROC curve [AUC] = 0.792, 95% confidence Interval [CI] 0.666-0.917) and in test cohort (AUC = 0.640, 95% CI 0.411-0.870). The AUCs of the delta-SAT RM were 0.777 (95% CI 0.648-0.907) in training cohort and 0.612 (95% CI 0.377-0.846) in test cohort. The combined nomogram model showed good discrimination for predicting disease progression, with a C-index of 0.808 and 0.702 in the training and test cohorts, respectively.
Conclusions: We first constructed a comprehensive model incorporating delta-adipose radiomics, baseline neutrophil-to-lymphocyte ratio (NLR) level and the application of biological therapy to predict progression in ileal stricturing CD, which aids in the timely adjustment of therapeutic strategies and enhances patients' quality of life.
Keywords: Crohn’s disease; Ileal structuring; Radiomics; Subcutaneous adipose tissue; Visceral adipose tissue.
© 2025. The Author(s) under exclusive licence to Japan Radiological Society.
Conflict of interest statement
Declarations. Conflict of interests: The authors have no relevant financial or nonfinancial interests to disclose. Ethics approval and consent to participate: The study received approval from the institutional review board (IRB No.2024-E367-01) and performed according to the principles of the Declaration of Helsinki, with a waiver granted for the requirement of obtaining informed consent.
Similar articles
-
Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn's disease patients.World J Gastroenterol. 2025 Jun 7;31(21):105895. doi: 10.3748/wjg.v31.i21.105895. World J Gastroenterol. 2025. PMID: 40538512 Free PMC article.
-
CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.EClinicalMedicine. 2022 Dec 30;56:101805. doi: 10.1016/j.eclinm.2022.101805. eCollection 2023 Feb. EClinicalMedicine. 2022. PMID: 36618894 Free PMC article.
-
Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab.World J Gastroenterol. 2025 Jul 21;31(27):109459. doi: 10.3748/wjg.v31.i27.109459. World J Gastroenterol. 2025. PMID: 40741098 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
References
-
- Pariente B, Cosnes J, Danese S, et al. Development of the Crohn’s disease digestive damage score, the Lemann score. Inflamm Bowel Dis. 2011;17(6):1415–22. - PubMed
-
- Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139(4):1147–55. - PubMed
-
- Tavares de Sousa H, Carneiro F. Understanding progression of strictures in ileal Crohn’s disease-the importance of setting methodological standards. United Eur Gastroenterol J. 2022;10(9):915–6.
-
- Li X, Zhang N, Hu C, et al. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn’s disease: a multicentre cohort study. EClinicalMedicine. 2023;56: 101805. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials